Vertex Pharmaceuticals Inc (NASDAQ:VRTX)

314.91
Delayed Data
As of Mar 31
 +2.75 / +0.88%
Today’s Change
233.01
Today|||52-Week Range
325.19
+9.05%
Year-to-Date
The 10 Best Stocks to Buy in April 2023
1:13pm / MotleyFool.com - Paid Partner Content
2 Top Stocks to Buy With $1,000 Right Now
Mar 30 / MotleyFool.com - Paid Partner Content
Here's a New Million-Dollar Reason to Buy CRISPR Therapeutics
5:30am / MotleyFool.com - Paid Partner Content
2 No-Brainer Stocks to Buy Before the Next Bull Market
Mar 30 / MotleyFool.com - Paid Partner Content
This Top Growth Stock Is Targeting a Multi-Billion-Dollar Market. Here's What It Means for Investors
Mar 31 / MotleyFool.com - Paid Partner Content
2 No-Brainer Growth Stocks to Buy and Hold for Years
Mar 30 / MotleyFool.com - Paid Partner Content
Have $2,000? 2 Exceptional Stocks to Buy In a Bear Market
Mar 31 / MotleyFool.com - Paid Partner Content
Better Growth Stock: Vertex Pharmaceuticals vs. AbbVie
Mar 29 / MotleyFool.com - Paid Partner Content
What Bear Market? These 2 Winning Stocks Are Still Worth Buying.
Mar 30 / MotleyFool.com - Paid Partner Content
Vertex (VRTX) Inks Licensing Deal With CRISPR for Diabetes Drug
Mar 28 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close312.16
Today’s open313.17
Day’s range312.18 - 315.39
Volume34,486
Average volume (3 months)1,322,541
Market cap$81.0B
Data as of 4:00pm ET, 03/31/2023

Growth & Valuation

Earnings growth (last year)+42.72%
Earnings growth (this year)-4.75%
Earnings growth (next 5 years)+10.50%
Revenue growth (last year)+15.04%
P/E ratio24.6
Price/Sales8.55
Price/Book5.82

Competitors

 Today’s
change
Today’s
% change
ZTSZoetis Inc+2.20+1.34%
----
GLAXFGlaxoSmithKline+0.79+4.59%
GSKGlaxoSmithKline+0.31+0.88%
Data as of 4:00pm ET, 03/31/2023

Financials

Next reporting dateMay 3, 2023
EPS forecast (this quarter)$3.07
Annual revenue (last year)$8.7B
Annual profit (last year)$3.3B
Net profit margin37.97%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
Boston, Massachusetts

Forecasts